Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer

BACKGROUND: Currently, immunotherapy is widely used for breast cancer (BC) patients, and tumor mutation burden (TMB) is regarded as a valuable independent predictor of response to immunotherapy. However, specific gene mutations and their relationship with TMB and tumor-infiltrating immune cells in B...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhiquan, Xiang, Ling, Wang, Rong, Xiong, Yongfu, Zhou, He, Gu, Haitao, Wang, Jijian, Peng, Linglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651385/
https://www.ncbi.nlm.nih.gov/pubmed/34888385
http://dx.doi.org/10.1155/2021/8072796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651385/
https://www.ncbi.nlm.nih.gov/pubmed/34888385
http://dx.doi.org/10.1155/2021/8072796

Ejemplares similares